Co-existing coronary artery disease in a patient with hypertrophic cardiomyopathy detected by 82Rb PET/CT myocardial perfusion study

By Parthiban Arumugam, MD
Data courtesy of Manchester Royal Infirmary, Manchester, England
|14.04.2018

A 58-year-old man with a history of hypertrophic cardiomyopathy (HCM) presented with tightness in the chest and occasional chest pain. The patient had previously been treated with alcohol septal ablation for a left ventricular outflow tract (LVOT) obstruction secondary to HCM. The patient also had several risk factors for coronary artery disease including high BMI (36), hypertension, and diabetes. In view of the clinical possibility of coronary artery disease coexisting with hypertrophic cardiomyopathy, the patient was referred to a stress-rest 82Rb PET/CT myocardial perfusion (MPI) study.

The 82Rb PET/CT MPI study was performed on a Biograph mCT™ PET/CT system. An initial dynamic acquisition at rest was performed following an 82Rb infusion. Following an adenosine stress infusion, 30 mCi 82Rb was injected and was immediately followed with a dynamic list-mode acquisition for 7 minutes. Both rest and stress PET imaging were preceded by a low-dose CT acquisition.

An initial 82Rb myocardial perfusion PET/CT study performed using vasodilator stress and at rest shows stress inducible perfusion abnormality in the mid-LAD distribution (white arrows). Additionally, there was severe reduction in tracer uptake in the mid/basal septum (orange arrows) due to iatrogenic infarct caused by alcohol injection to relieve LV outflow tract obstruction. Furthermore, significant stress-induced LV cavity dilatation is visualized and LV ejection fraction was preserved
Figure 1

As evident from stress-rest images obtained from the initial 82Rb MPI PET/CT study (Figure 1), there is a large reversible perfusion defect in the anterior wall and apex as well as an adjacent septum reflecting inducible ischemia in the left anterior descending (LAD) territory. The fixed perfusion defect in the upper and basal septum reflects alcohol injection related to the ablation performed previously for relief of left ventricular (LV) outflow obstruction secondary to hypertrophic cardiomyopathy. Significant stress induced LV dilatation reflects the severity of the LAD territory ischemia with complete reversibility of the ischemic zone demonstrated by normal LAD territory uptake and normal LV cavity size at rest. In view of the PET/CT demonstrated LAD territory reversible ischemia, the patient underwent cardiac catheterization.

A coronary angiography showed significant stenosis in proximal LAD, which correlated with LAD territory ischemia demonstrated on the PET MPI
Figure 2

In view of the significant LAD stenosis demonstrated on the coronary angiography (Figure 2), the patient underwent stenting of the LAD lesion. Coronary angiography identified additional plaques in the mid- and distal LAD and left circumflex, which were not considered flow limiting and therefore intervention for the plaques was not performed. Angiographic images acquired immediately following stent placement showed a normal LAD flow restored (Figure 3). A follow-up 82Rb stress-rest PET/CT MPI study was performed one year post-percutaneous coronary intervention (PCI) as the patient was admitted with troponin negative chest pain. The study was performed to assess the significance of plaque disease elsewhere, to ensure stent patency, and to rule out microvascular ischemia. The repeat PET/CT study was performed using exactly the same acquisition protocol as the initial study.

As evident from Figure 4, the follow-up 82Rb stress-rest MPI study shows normal perfusion in the LAD territory, which reflects patent LAD stent. A comparison of pre- and post-stent MPI studies show significant improvement in LAD territory perfusion along with a gross reduction in transient ischemic dilatation as seen in the follow-up study and reflects the reduction of LAD territory ischemia following the stent placement. The basal septal fixed perfusion defect related to alcohol ablation of the upper septum for the LVOT obstruction relief appears similar to that seen in the initial MPI study. Overall, the impression from the follow-up 82Rb PET/CT shows significant improvement in the LAD territory perfusion and reflects a successful stenting of proximal LAD stenosis in this patient with coronary artery disease co-existing with hypertrophic cardiomyopathy.

Following the percutaneous transluminal coronary angioplasty (PTCA) and stent placement, angiographic images show restoration of normal flow in the LAD and branche
Figure 3

Patients with hypertrophic cardiomyopathy may have angina as a dominant symptom. Co-existing coronary artery disease in patients with hypertrophic cardiomyopathy has been reported in 25% of patients with HCM who are over 45 years of age.1 Evaluation of these patients should consider the pathophysiology of both LVOT obstruction and consequent ventricular dilatation secondary to an HCM. Additionally, ischemia should be evaluated secondary to coronary stenosis since the clinical effect may be disproportionate to the severity due to myocardial hypertrophy. In the current patient, initial evaluation and therapy was primarily driven by the focus on relieving the LVOT obstruction, for which basal septal alcohol ablation was performed. Any symptoms related to co-existing coronary artery disease may have been attributed to the LVOT obstruction initially. Persistent angina-like symptoms (even after relief of LVOT obstruction) led to consideration of the possibility of co-existing coronary artery disease.

A stress-rest 82Rb MPI PET/CT scan clearly demonstrates reversible ischemia in the LAD territory, which correlated with proximal LAD stenosis seen on the angiogram. Following LAD stenting, there was symptomatic relief of angina with normal perfusion to the LAD territory restored as demonstrated by the follow-up 82Rb MPI PET/CT. In spite of the obesity (BMI 36), the 82Rb perfusion PET images show excellent image quality, definition of uptake within myocardium as well as clear definition of ischemic zone, reversibility as well as fixed perfusion defects in the basal septal ablation zone. The image quality of such a study is a testament to the high count rates achieved by the Biograph mCT PET/CT system as well as the robustness of the CT attenuation correction in PET/CT technology. The dynamic imaging acquired with PET/CT during and immediately following vasodilator infusion (which helps to clearly define post stress LV dilatation) reflects the severity of myocardial ischemia and is another helpful indicator of disease severity.

In the current patient, although the significant stenosis is limited to the proximal LAD, the significant post-stress LV dilatation is most likely related to the large extent of LV territory ischemia caused by stenosis of a dominant LAD. Stenting of the proximal LAD lesion demonstrated complete resolution of ischemia and post-stress LV dilatation as seen in the follow-up study. This further confirms that the LAD lesion was the only culprit lesion and the additional coronary plaques were not clinically significant.

A follow-up 82Rb myocardial perfusion PET/CT study performed with vasodilator stress and at rest shows normal perfusion in the anterior wall, apex, and adjacent septum (white arrows) both at stress and rest, which suggests absence of functionally significant ischemia in the LAD territory. The LV cavity size following stress appears normal with minimal change between stress and rest. Absence of transient ischemic dilatation suggests absence of gross ischemia. Fixed perfusion defect in the basal septum (orange arrows) reflect an alcohol injection related upper septal ablation
Figure 4

An 82Rb dynamic PET/CT myocardial perfusion study performed during vasodilator stress and at rest shows inducible ischemia involving the entire LAD territory in a patient with hypertrophic cardiomyopathy. Coronary angiography revealed tight proximal LAD stenosis, which was stented with restoration of myocardial perfusion demonstrated on a follow-up PET/CT study.

Scanner: Biograph mCT

PET

 

Injected dose

30 mCi 82Rb infusion stress and rest

Acquisition

Dynamic

Reconstruction parameters

128 matrix; zoom 1.3

CT

 

Tube voltage

120 kV

Tube current

30 mAs

Slice thickness

3 mm

1